Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria to Sweden-based Atlas Antibodies in a deal that values Evitria at more than EUR 200m.
Vehicle will continue to make early-stage investments in European digital technology startups
Dutch minority investment specialist has surpassed its EUR 200m target at its first close
Growth fund has a EUR 150m target and expects to announce its first investment shortly
Hellman & Friedman increased its take-private offer to EUR 3.29bn earlier this week